R.P. Products Pharma Equipments Profile
Key Indicators
- Authorised Capital ₹ 4.70 Cr
- Paid Up Capital ₹ 2.31 Cr
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.19 Cr
- Satisfied Charges ₹ 10.05 Cr
- Revenue Growth -20.57%
- Profit Growth -208.08%
- Ebitda -39.05%
- Net Worth -8.03%
- Total Assets 1.36%
About R.P. Products Pharma Equipments
R.P. Products Pharma Equipments Pvt. Ltd. (RPPEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 March 2007 and has a history of 17 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.70 Cr and a paid-up capital of Rs 2.31 Cr.
The company currently has active open charges totaling ₹14.19 Cr. The company has closed loans amounting to ₹10.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ratnakar Patwardhan, Meenal Patwardhan, and Rahul Patwardhan serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U29297MH2007PTC168634
- Company No.
168634
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at R.P. Products Pharma Equipments?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratnakar Patwardhan  | Director | 12-Mar-2007 | Current |
| Meenal Patwardhan | Director | 12-Mar-2007 | Current |
| Rahul Patwardhan | Director | 10-Jan-2009 | Current |
Financial Performance of R.P. Products Pharma Equipments.
R.P. Products Pharma Equipments Pvt. Ltd., for the financial year ended 2023, experienced significant reduction in revenue, with a 20.57% decrease. The company also saw a substantial fall in profitability, with a 208.08% decrease in profit. The company's net worth dipped by a decrease of 8.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.P. Products Pharma Equipments?
In 2023, R.P. Products Pharma Equipments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹14.19 Cr
₹10.05 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 14.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2024 | Axis Bank Limited | ₹0.81 M | Open |
| 28 Feb 2024 | Axis Bank Limited | ₹1.00 Cr | Open |
| 29 Apr 2022 | Axis Bank Limited | ₹9.00 M | Open |
| 23 Apr 2021 | Axis Bank Limited | ₹8.84 M | Open |
| 28 Feb 2019 | Axis Bank Limited | ₹1.70 Cr | Open |
How Many Employees Work at R.P. Products Pharma Equipments?
Unlock and access historical data on people associated with R.P. Products Pharma Equipments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.P. Products Pharma Equipments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.P. Products Pharma Equipments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
